Raymond James & Associates’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$2.75M Buy
29,592
+748
+3% +$69.5K ﹤0.01% 2021
2024
Q2
$2.37M Sell
28,844
-637
-2% -$52.4K ﹤0.01% 2051
2024
Q1
$1.96M Buy
29,481
+1,356
+5% +$90K ﹤0.01% 2164
2023
Q4
$1.6M Buy
28,125
+3,298
+13% +$187K ﹤0.01% 2223
2023
Q3
$1.35M Buy
24,827
+967
+4% +$52.7K ﹤0.01% 2252
2023
Q2
$1.61M Buy
23,860
+2,779
+13% +$187K ﹤0.01% 2183
2023
Q1
$1.09M Buy
21,081
+1,539
+8% +$79.2K ﹤0.01% 2395
2022
Q4
$899K Buy
19,542
+3,489
+22% +$161K ﹤0.01% 2485
2022
Q3
$814K Buy
16,053
+1,543
+11% +$78.2K ﹤0.01% 2521
2022
Q2
$661K Buy
14,510
+1,775
+14% +$80.9K ﹤0.01% 2718
2022
Q1
$592K Sell
12,735
-1,721
-12% -$80K ﹤0.01% 2953
2021
Q4
$726K Buy
14,456
+3,934
+37% +$198K ﹤0.01% 2828
2021
Q3
$559K Buy
10,522
+686
+7% +$36.4K ﹤0.01% 2978
2021
Q2
$600K Buy
9,836
+1,859
+23% +$113K ﹤0.01% 2948
2021
Q1
$389K Buy
+7,977
New +$389K ﹤0.01% 3168
2020
Q4
Sell
-39,173
Closed -$1.27M 3669
2020
Q3
$1.27M Sell
39,173
-1,411
-3% -$45.9K ﹤0.01% 2023
2020
Q2
$1.07M Sell
40,584
-379
-0.9% -$10K ﹤0.01% 2112
2020
Q1
$1.02M Sell
40,963
-19,007
-32% -$474K ﹤0.01% 1962
2019
Q4
$2.16M Buy
59,970
+31,378
+110% +$1.13M ﹤0.01% 1777
2019
Q3
$977K Sell
28,592
-521
-2% -$17.8K ﹤0.01% 2214
2019
Q2
$815K Buy
29,113
+1,661
+6% +$46.5K ﹤0.01% 2337
2019
Q1
$851K Sell
27,452
-44
-0.2% -$1.36K ﹤0.01% 2295
2018
Q4
$650K Buy
27,496
+2,201
+9% +$52K ﹤0.01% 2364
2018
Q3
$980K Buy
25,295
+5,010
+25% +$194K ﹤0.01% 2267
2018
Q2
$679K Buy
+20,285
New +$679K ﹤0.01% 2472
2017
Q4
Sell
-5,362
Closed -$201K 3336
2017
Q3
$201K Sell
5,362
-4,024
-43% -$151K ﹤0.01% 3023
2017
Q2
$293K Sell
9,386
-89
-0.9% -$2.78K ﹤0.01% 2724
2017
Q1
$233K Buy
+9,475
New +$233K ﹤0.01% 2816